Wei Ling Pian
Natural health product licensed in Canada
- Licence holder
- Eastern Currents Ltd.
- NPN or DIN-HM
- 80038523
- Status
- Inactive licence
- Licence date
- 3 January 2013
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Glycyrrhiza uralensis Fisch.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Atractylodes lancea Source : Rhizome Extraction ratio : 7:1 Dry plant equivalent : 455 mg | 65 mg | Not calculated |
| Cinnamomum aromaticum Source : Écorce Extraction ratio : 7:1 Dry plant equivalent : 140 mg | 20 mg | Not calculated |
| Zingiber officinale Source : Rhizome Extraction ratio : 7:1 Dry plant equivalent : 175 mg | 25 mg | Not calculated |
| Tetrapanax papyrifer Source : Stem pith Extraction ratio : 7:1 Dry plant equivalent : 280 mg | 40 mg | Not calculated |
| Glycyrrhiza uralensis Source : Root (honey-fried) Extraction ratio : 7:1 Dry plant equivalent : 175 mg | 25 mg | Not calculated |
| Alisma orientale Source : Rhizome Extraction ratio : 7:1 Dry plant equivalent : 315 mg | 45 mg | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Acide stéarique, Gomme de cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Product manufactured based on Traditional Chinese Medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80038523
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.